1. Home
  2. Clinical Topics
  3. FDA approvals—July 11-12, 2016
Clinical TopicsDrugs and DevicesNewsWeb Exclusives

FDA approvals—July 11-12, 2016

Share

On July 12, the Food and Drug Administration (FDA) approved Xiidra (lifitegrast ophthalmic solution) for the treatment of signs and symptoms of dry eye disease. Read more

 

On July 11, the FDA approved the first focused ultrasound device, ExAblate Neuro, to treat essential tremor in patients who have not responded to medication. Read more

Leave a Reply

Your email address will not be published.

Fill out this field
Fill out this field
Please enter a valid email address.

Get your free subscription to NurseLine!

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts